litlas
ログインアカウント作成

D. Gary Gilliland

1980–2025 年に発表

別表記
D.Gary Gilliland
171
論文数
63,897
被引用数
123
h 指数
170
i10 指数

被引用数

D. Gary Gilliland の年別被引用数1981 年: 被引用 1 件1982 年: 被引用 7 件1983 年: 被引用 2 件1985 年: 被引用 1 件1986 年: 被引用 2 件1987 年: 被引用 1 件1988 年: 被引用 2 件1989 年: 被引用 4 件1990 年: 被引用 1 件1991 年: 被引用 1 件1992 年: 被引用 5 件1993 年: 被引用 3 件1994 年: 被引用 22 件1995 年: 被引用 32 件1996 年: 被引用 69 件1997 年: 被引用 100 件1998 年: 被引用 119 件1999 年: 被引用 154 件2000 年: 被引用 200 件2001 年: 被引用 187 件2002 年: 被引用 337 件2003 年: 被引用 421 件2004 年: 被引用 475 件2005 年: 被引用 638 件2006 年: 被引用 702 件2007 年: 被引用 942 件2008 年: 被引用 992 件2009 年: 被引用 913 件2010 年: 被引用 1,021 件2011 年: 被引用 944 件2012 年: 被引用 944 件2013 年: 被引用 787 件2014 年: 被引用 753 件2015 年: 被引用 651 件2016 年: 被引用 545 件2017 年: 被引用 593 件2018 年: 被引用 441 件2019 年: 被引用 1,402 件2020 年: 被引用 1,418 件2021 年: 被引用 1,304 件2022 年: 被引用 912 件2023 年: 被引用 632 件2024 年: 被引用 947 件2025 年: 被引用 370 件2026 年: 被引用 18 件1984 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 7,279 件、この内訳の 34.1%中国: 引用元論文 2,026 件、この内訳の 9.5%ドイツ: 引用元論文 1,447 件、この内訳の 6.8%イギリス: 引用元論文 1,439 件、この内訳の 6.7%イタリア: 引用元論文 935 件、この内訳の 4.4%フランス: 引用元論文 896 件、この内訳の 4.2%日本: 引用元論文 731 件、この内訳の 3.4%カナダ: 引用元論文 676 件、この内訳の 3.2%オランダ: 引用元論文 536 件、この内訳の 2.5%オーストラリア: 引用元論文 527 件、この内訳の 2.5%スイス: 引用元論文 491 件、この内訳の 2.3%スペイン: 引用元論文 453 件、この内訳の 2.1%
0%34.1%その他 18.3%

機関

分野

  • Medicine57%
  • Biochemistry, Genetics and Molecular Biology35.4%
  • Immunology and Microbiology4.8%
  • Computer Science0.8%
  • Neuroscience0.6%
  • Chemistry0.5%
  • その他0.9%

トピック

  • Acute Myeloid Leukemia Research8%
  • Chronic Myeloid Leukemia Treatments4.5%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment4.4%
  • Epigenetics and DNA Methylation3.2%
  • Eosinophilic Disorders and Syndromes2.3%
  • Acute Lymphoblastic Leukemia research2.1%
  • その他75.5%

共著者

全論文

検索で開く
  1. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1

    著者: David A. Barbie, Pablo Tamayo, Jesse S. Boehm, So Young Kim, Susan E. Moody, Ian F. Dunn, Anna C. Schinzel, Péter Sandy, Etienne Meylan, Claudia Scholl, Stefan Fröhling, Edmond M. Chan, Martin L. Sos, Kathrin Michel, Craig H. Mermel, Serena J. Silver, Barbara A. Weir, Jan H. Reiling, Qing Sheng, Piyush B. Gupta, Raymond Wadlow, Hanh Le, Sebastian Hoersch, Ben S. Wittner, Sridhar Ramaswamy, David M. Livingston, David M. Sabatini, Matthew Meyerson, Roman K. Thomas, Eric S. Lander, Jill P. Mesirov, David E. Root, D. Gary Gilliland, Tyler Jacks, William C. Hahn - Nature 2009 被引用: 4,263

  2. Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9

    著者: Andrei V. Krivtsov, David Twomey, Zhaohui Feng, Matthew C. Stubbs, Yingzi Wang, Joerg Faber, Jason Levine, Jing Wang, William C. Hahn, D. Gary Gilliland, Todd R. Golub, Scott A. Armstrong - Nature 2006 被引用: 1,541

  3. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

    著者: Ross L. Levine, Martha Wadleigh, Jan Cools, Benjamin L. Ebert, Gerlinde Wernig, Brian J.P. Huntly, Titus J. Boggon, Iwona Włodarska, Jennifer Clark, Sandra Moore, Jennifer Adelsperger, Sumin Koo, Jeffrey C. Lee, Stacey Gabriel, Thomas Mercher, Alan D. D’Andrea, Stefan Fröhling, Konstanze Döhner, Peter Marynen, Peter Vandenberghe, Ruben A. Mesa, Ayalew Tefferi, James D. Griffin, Michael J. Eck, William R. Sellers, Matthew Meyerson, Todd R. Golub, Stephanie J. Lee, D. Gary Gilliland - Cancer Cell 2005 被引用: 2,991

  4. Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors

    著者: Erick J. Morris, Sharda Jha, Clifford R. Restaino, Priya Dayananth, Hugh Zhu, Alan Cooper, Donna Carr, Yongi Deng, Weihong Jin, Stuart Black, Brian J. Long, Jenny Liu, Edward DiNunzio, William T. Windsor, Rumin Zhang, Shuxia Zhao, Minilik Angagaw, Elaine M. Pinheiro, Jagdish Desai, Li Xiao, Gerald W. Shipps, Alan Hruza, James Wang, Joe Kelly, Sunil Paliwal, Xiaolei Gao, Boga Sobhana Babu, Liang Zhu, Pierre Daublain, Ling Zhang, Bart Lutterbach, Marc R. Pelletier, Ulrike Philippar, Phieng Siliphaivanh, David Witter, Paul T. Kirschmeier, W. Robert Bishop, Daniel J. Hicklin, D. Gary Gilliland, Lata Jayaraman, Leigh Zawel, Stephen E. Fawell, Ahmed A. Samatar - Cancer Discovery 2013 被引用: 685

  5. Tyrosine Phosphorylation Inhibits PKM2 to Promote the Warburg Effect and Tumor Growth

    著者: Taro Hitosugi, Sumin Kang, Matthew G. Vander Heiden, Tae‐Wook Chung, Shannon Elf, Katherine Lythgoe, Shaozhong Dong, Sagar Lonial, Xu Wang, Georgia Z. Chen, Jianxin Xie, Ting-Lei Gu, Roberto D. Polakiewicz, Johannes Roesel, Titus J. Boggon, Fadlo R. Khuri, D. Gary Gilliland, Lewis C. Cantley, Jonathan L. Kaufman, Jing Chen - Science Signaling 2009 被引用: 781

  6. The roles of FLT3 in hematopoiesis and leukemia

    著者: D. Gary Gilliland, James D. Griffin - Blood 2002 被引用: 1,554

  7. Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl

    著者: Ellen Weisberg, Paul W. Manley, Werner Breitenstein, Josef Brüggen, Sandra W. Cowan‐Jacob, Arghya Ray, Brian J.P. Huntly, Doriano Fabbro, Gabriele Fendrich, Elizabeth Hall–Meyers, Andrew L. Kung, Jürgen Mestan, George Q. Daley, Linda M. Callahan, Laurie Catley, Cara Cavazza, Mohammad Azam, Donna Neuberg, Renee D. Wright, D. Gary Gilliland, James D. Griffin - Cancer Cell 2005 被引用: 1,483

  8. FoxOs Are Critical Mediators of Hematopoietic Stem Cell Resistance to Physiologic Oxidative Stress

    著者: Zuzana Tóthová, Ramya Kollipara, Brian J.P. Huntly, Benjamin H. Lee, Diego H. Castrillón, Dana E. Cullen, Elizabeth McDowell, Suzan Lazo-Kallanian, Ifor R. Williams, Christopher Sears, Scott A. Armstrong, Emmanuelle Passegué, Ronald A. DePinho, D. Gary Gilliland - Cell 2007 被引用: 1,559

  9. Unifying mechanism for different fibrotic diseases

    著者: Gerlinde Wernig, Shih‐Yu Chen, Lu Cui, Camille Van Neste, Jonathan M. Tsai, Neeraja Kambham, Hannes Vogel, Yasodha Natkunam, D. Gary Gilliland, Garry P. Nolan, Irving L. Weissman - National Academy of Sciences, Proceedings of the National Academy of Sciences 2017 被引用: 210

  10. The interferon-stimulated gene RIPK1 regulates cancer cell intrinsic and extrinsic resistance to immune checkpoint blockade

    著者: Lisa Cucolo, Qingzhou Chen, Jingya Qiu, Yongjun Yu, Max Klapholz, Krista A. Budinich, Zhaojun Zhang, Yue Shao, Igor E. Brodsky, Martha S. Jordan, D. Gary Gilliland, Nancy R. Zhang, Junwei Shi, Andy J. Minn - Immunity 2022 被引用: 91

  11. MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia

    著者: Yana Pikman, Benjamin H. Lee, Thomas Mercher, Elizabeth McDowell, Benjamin L. Ebert, Maricel Gozo, Adam Cuker, Gerlinde Wernig, Sandra Moore, Ilene Galinsky, Daniel J. DeAngelo, Jennifer Clark, Stephanie J. Lee, Todd R. Golub, Martha Wadleigh, D. Gary Gilliland, Ross L. Levine - PLoS Medicine 2006 被引用: 1,415

  12. JAK2 Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis

    著者: Linda M. Scott, Wei Tong, Ross L. Levine, Mike Scott, Philip Beer, Michael R. Stratton, P. Andrew Futreal, Wendy N. Erber, Mary Frances McMullin, Claire Harrison, Alan J. Warren, D. Gary Gilliland, Harvey F. Lodish, Anthony R. Green - New England Journal of Medicine 2007 被引用: 1,248

  13. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia

    著者: Adolfo A. Ferrando, Donna Neuberg, Jane Staunton, Mignon L. Loh, Christine Huard, Susana C. Raimondi, Fred G. Behm, Ching‐Hon Pui, James R. Downing, D. Gary Gilliland, Eric S. Lander, Todd R. Golub, A. Thomas Look - Cancer Cell 2002 被引用: 1,122

  14. Activating mutations in ALK provide a therapeutic target in neuroblastoma

    著者: Rani E. George, Takaomi Sanda, Megan Hanna, Stefan Fröhling, William Luther, Jianming Zhang, Yebin Ahn, Wenjun Zhou, Wendy B. London, Patrick McGrady, Liquan Xue, Sergey Zozulya, V. Gregor, Thomas R. Webb, Nathanael S. Gray, D. Gary Gilliland, Lisa Diller, Heidi Greulich, Stephan W. Morris, Matthew Meyerson, A. Thomas Look - Nature 2008 被引用: 899

  15. FoxOs Are Lineage-Restricted Redundant Tumor Suppressors and Regulate Endothelial Cell Homeostasis

    著者: Ji-Hye Paik, Ramya Kollipara, Gerald Chu, Hongkai Ji, Yonghong Xiao, Zhihu Ding, Lili Miao, Zuzana Tóthová, James W. Horner, Daniel R. Carrasco, Shan Jiang, D. Gary Gilliland, Lynda Chin, Wing H. Wong, Diego H. Castrillón, Ronald A. DePinho - Cell 2007 被引用: 1,040

  16. Phase IIB Trial of Oral Midostaurin (PKC412), the FMS-Like Tyrosine Kinase 3 Receptor (FLT3) and Multi-Targeted Kinase Inhibitor, in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome With Either Wild-Type or Mutated FLT3

    著者: Thomas Fischer, Richard M. Stone, Daniel J. DeAngelo, Ilene Galinsky, Elihu H. Estey, Carlo Lanza, Edward Fox, Gerhard Ehninger, Eric J. Feldman, Gary J. Schiller, Virginia M. Klimek, Stephen D. Nimer, D. Gary Gilliland, Catherine Dutreix, Alice Huntsman-Labed, J. D. Virkus, Francis J. Giles - Journal of Clinical Oncology 2010 被引用: 502

  17. Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis

    著者: Raajit K. Rampal, Fátima Al‐Shahrour, Omar Abdel‐Wahab, Jay Pravin Patel, Jean-Philippe Brunel, Craig H. Mermel, Adam J. Bass, Jennifer Pretz, Jihae Ahn, Todd Hricik, Outi Kilpivaara, Martha Wadleigh, Lambert Busque, D. Gary Gilliland, Todd R. Golub, Benjamin L. Ebert, Ross L. Levine - Blood 2014 被引用: 428

  18. Runx1 Deficiency Decreases Ribosome Biogenesis and Confers Stress Resistance to Hematopoietic Stem and Progenitor Cells

    著者: Xiongwei Cai, Long Gao, Li Teng, Jingping Ge, Zaw Min Oo, Ashish Kumar, D. Gary Gilliland, Philip J. Mason, Kai Tan, Nancy A. Speck - Cell stem cell 2015 被引用: 239

  19. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia

    著者: Woo‐Joo Song, Melanie G. Sullivan, Robert D. Legare, Sarah Hutchings, Xiaolian Tan, Dubravka Kufrin, Janina Ratajczak, Isabel C. Resende, C Haworth, Randy A. Hock, Mignon L. Loh, Carolyn A. Felix, Denis‐Claude Roy, Lambert Busque, David M. Kurnit, Cheryl L. Willman, Alan M. Gewirtz, Nancy A. Speck, John H. Bushweller, Frederick P. Li, Katheleen Gardiner, Mortimer Poncz, John M. Maris, D. Gary Gilliland - Nature Genetics 1999 被引用: 1,100

  20. MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

    著者: Animesh Pardanani, Ross L. Levine, Terra L. Lasho, Yana Pikman, Ruben A. Mesa, Martha Wadleigh, David P. Steensma, Michelle A. Elliott, Alexandra P. Wolanskyj, William J. Hogan, Rebecca F. McClure, Mark R. Litzow, D. Gary Gilliland, Ayalew Tefferi - Blood 2006 被引用: 1,039

  21. Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia

    著者: Michael G. Kharas, Christopher J. Lengner, Fátima Al‐Shahrour, Lars Bullinger, Brian Ball, Samir Zaidi, Kelly Morgan, Winnie F. Tam, Mahnaz Paktinat, Rachel Okabe, Maricel Gozo, William S. Einhorn, Steven Lane, Claudia Scholl, Stefan Fröhling, Mark D. Fleming, Benjamin L. Ebert, D. Gary Gilliland, Rudolf Jaenisch, George Q. Daley - Nature Medicine 2010 被引用: 398

  22. Physiological Jak2V617F Expression Causes a Lethal Myeloproliferative Neoplasm with Differential Effects on Hematopoietic Stem and Progenitor Cells

    著者: Ann Mullally, Steven Lane, Brian Ball, Christine Megerdichian, Rachel Okabe, Fátima Al‐Shahrour, Mahnaz Paktinat, J. Erika Haydu, Elizabeth Housman, Allegra M. Lord, Gerlinde Wernig, Michael G. Kharas, Thomas Mercher, Jeffery L. Kutok, D. Gary Gilliland, Benjamin L. Ebert - Cancer Cell 2010 被引用: 392

  23. Direct inhibition of the NOTCH transcription factor complex

    著者: Raymond E. Moellering, Melanie Cornejo, Tina Davis, Cristina Del Bianco, Jon C. Aster, Stephen C. Blacklow, Andrew L. Kung, D. Gary Gilliland, Gregory L. Verdine, James E. Bradner - Nature 2009 被引用: 755

  24. Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders

    著者: Ross L. Levine, Animesh Pardanani, Ayalew Tefferi, D. Gary Gilliland - Nature reviews. Cancer 2007 被引用: 590